CST2 expression is significantly up-regulated in GC samples, which enhances the growth, migration, and invasion of GC cells by regulating epithelial-mesenchymal transition (EMT) and TGF-β1 signaling pathways, leading to poor prognosis in GC patients (Zhang et al., 2020). The gene discussed is CST2; the disease is gastric cancer.